GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis.
about
Different ovarian stimulation protocols for women with diminished ovarian reservePoor ovarian reserveStrategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysisComparison of gonadotropin-releasing hormone agonist with GnRH antagonist in polycystic ovary syndrome patients undergoing in vitro fertilization cycle: Retrospective analysis from a tertiary center and review of literatureGnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles.Comparison of different ovarian hyperstimulation protocols efficacy in poor ovarian responders according to the Bologna criteriaFemale infertility.Management of poor responders in IVF: is there anything new?Obesity is not associated with the poor pregnancy outcome following intracytoplasmic sperm injection in women with polycystic ovary syndrome.Treatment options for polycystic ovary syndrome.The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist.New algorithm for OHSS preventionGnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSIEffectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF/ICSI.Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist ProtocolCan steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome.A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience.Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles.Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study.Is there an ideal stimulation regimen for IVF for poor responders and does it change with age?Effect of Pre-ovulatory Single Dose GnRH agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective StudyStrategies for Pituitary Down-regulation to Optimize IVF/ICSI Outcome in Poor Ovarian Responders.Early pregnancy loss rates were different among singleton gestations conceived by ICSI using GnRH agonist and antagonistPolycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies.Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles.Assessing the optimal dose for Cetrorelix in Chinese women undergoing ovarian stimulation during the course of IVF-ET treatment.GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology.GnRH Antagonist IVF Protocol in PCOS.Gonadotrophin-releasing hormone-antagonists vs long agonist in in-vitro fertilization patients with polycystic ovary syndrome: a meta-analysis.Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis.Which is the best IVF/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial.The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.Retrospective cohort study: AMH is the best ovarian reserve markers in predicting ovarian response but has unfavorable value in predicting clinical pregnancy in GnRH antagonist protocol.Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?Serum and follicular fluid levels of IGF-II, IGF-binding protein-4 and pregnancy-associated plasma protein-A in controlled ovarian hyperstimulation cycle between polycystic ovarian syndrome (PCOS) and non-PCOS women.The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation.Could the addition of hp-hMG and GnRH antagonists modulate the response in IVF-ICSI cycles?GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.
P2860
Q24634342-0E10D587-385B-4E15-8C53-4C0BDF75017AQ26744379-1918CC25-9D03-4902-98EF-3D77BE916FBEQ28070299-ED2D9D20-EF85-4C59-BC10-988B6E191141Q33601506-147472FF-FB8D-4F24-A157-35E3E85883B4Q33744049-1E7FB851-8034-4DB8-B5A0-B41F842D33B0Q33756357-661B5156-2601-405F-8690-3A0498765533Q33846768-836A85CB-6BCF-4028-B740-94126867A7E2Q34022512-6C9845B3-30E2-4309-8F83-C155DE50B3A3Q34330406-B8C5AB59-08EC-46D5-B0D0-61D21D0C7755Q34574136-9FDDA5BA-0375-47B2-AF3B-4021E4B961D5Q35186161-2AC265BC-83D4-40E1-A4B3-B719E0F91382Q35591046-E8C489A2-2050-41BB-9505-27F8E451BE40Q35767881-C6CEF000-B287-4CAD-B794-2F6B6AFF4C13Q35925814-F6A5BD28-D601-4793-B428-AAA90C88D038Q35947620-7789C4B6-C5E8-49D7-A9BF-F523C346628AQ36085346-A074CDB8-5BA0-4206-BB38-DB1F97EF544DQ36327270-95B3A3E6-C162-4282-AB4C-EA4EDEABB030Q36385538-25795768-DBE9-4550-BA8D-8A2347B5C1C9Q36542509-B95365D2-E0D7-4E80-BED1-141659A9761EQ36970408-B9C0A627-0B75-4F5E-A890-AFF0FA8ABACBQ36995791-B6682363-C7F2-4CD8-A882-245B865C9E9BQ37035301-9A59FA85-5EFA-4D97-BEF3-D7072E9A09D2Q37035354-25B28E18-4D12-4004-8906-5997AECCB554Q37192437-8F602D85-2E24-46E3-8984-A1E4E694BABAQ37347738-E5F505D7-4278-44C6-9026-C57196E4059EQ37362849-DA8E624E-B8F7-475C-82A7-DE6507F2286CQ37369079-D8EEFEEB-5D04-4E26-8877-01F69A22D02EQ37598922-7D50B6FB-D669-41F1-ACD1-4610F1DFFDCDQ37622459-13243C7B-5A40-4F26-A4FD-542F58FE44F3Q37813637-AFF3F204-03CC-4A73-97B8-2C7B396E264FQ38063549-37416ABF-529E-4C0E-9B3D-F31470CF7769Q38402894-08509D9B-7A5A-492D-9C11-FC392243D3B3Q38924361-6B8D2C8C-DF94-489C-A529-99C206715355Q39067260-18BD8865-FF69-4455-B430-98D924CF3824Q41654195-A786AD42-D675-42F4-A83A-3D43C81A6383Q42506190-D80EA7D9-6180-494B-8C4C-9B9E659478B5Q45371053-E7033EA8-AFE9-492C-8EC3-536C382B5358Q48653020-3418633C-81A5-43CC-99AE-C146F88D0CD8Q48701805-62DA2619-4D09-4DD7-AD12-DF452FBAD21CQ48703957-BA6278D9-7C8E-469A-A72E-E3A410666F27
P2860
GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
GnRH-antagonists in ovarian st ...... rstimulation: a meta-analysis.
@ast
GnRH-antagonists in ovarian st ...... rstimulation: a meta-analysis.
@en
GnRH-antagonists in ovarian st ...... rstimulation: a meta-analysis.
@nl
type
label
GnRH-antagonists in ovarian st ...... rstimulation: a meta-analysis.
@ast
GnRH-antagonists in ovarian st ...... rstimulation: a meta-analysis.
@en
GnRH-antagonists in ovarian st ...... rstimulation: a meta-analysis.
@nl
prefLabel
GnRH-antagonists in ovarian st ...... rstimulation: a meta-analysis.
@ast
GnRH-antagonists in ovarian st ...... rstimulation: a meta-analysis.
@en
GnRH-antagonists in ovarian st ...... rstimulation: a meta-analysis.
@nl
P2093
P921
P1476
GnRH-antagonists in ovarian st ...... rstimulation: a meta-analysis.
@en
P2093
B C Tarlatzis
E M Kolibianakis
G Griesinger
K Diedrich
P304
P356
10.1016/S1472-6483(10)60652-9
P577
2006-11-01T00:00:00Z